101 related articles for article (PubMed ID: 15080907)
1. Homology modeling and molecular dynamics studies of a novel C3-like ADP-ribosyltransferase.
Xiao JF; Li ZS; Sun CC
Bioorg Med Chem; 2004 May; 12(9):2035-41. PubMed ID: 15080907
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
3. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
Vogelsgesang M; Aktories K
Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the Clostridium limosum C3 exoenzyme.
Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
[TBL] [Abstract][Full Text] [Related]
5. A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3.
Wilde C; Chhatwal GS; Schmalzing G; Aktories K; Just I
J Biol Chem; 2001 Mar; 276(12):9537-42. PubMed ID: 11124969
[TBL] [Abstract][Full Text] [Related]
6. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
Wilde C; Vogelsgesang M; Aktories K
Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
[TBL] [Abstract][Full Text] [Related]
7. C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure.
Evans HR; Holloway DE; Sutton JM; Ayriss J; Shone CC; Acharya KR
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1502-5. PubMed ID: 15272191
[TBL] [Abstract][Full Text] [Related]
8. Rho-ADP-ribosylating exoenzyme from Bacillus cereus. Purification, characterization, and identification of the NAD-binding site.
Just I; Selzer J; Jung M; van Damme J; Vandekerckhove J; Aktories K
Biochemistry; 1995 Jan; 34(1):334-40. PubMed ID: 7819216
[TBL] [Abstract][Full Text] [Related]
9. Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum--analysis of glutamic acid 174.
Böhmer J; Jung M; Sehr P; Fritz G; Popoff M; Just I; Aktories K
Biochemistry; 1996 Jan; 35(1):282-9. PubMed ID: 8555186
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of C3stau2 from Staphylococcus aureus and its complex with NAD.
Evans HR; Sutton JM; Holloway DE; Ayriss J; Shone CC; Acharya KR
J Biol Chem; 2003 Nov; 278(46):45924-30. PubMed ID: 12933793
[TBL] [Abstract][Full Text] [Related]
11. Substrate binding and catalysis of ecto-ADP-ribosyltransferase 2.2 from rat.
Ritter H; Koch-Nolte F; Marquez VE; Schulz GE
Biochemistry; 2003 Sep; 42(34):10155-62. PubMed ID: 12939142
[TBL] [Abstract][Full Text] [Related]
12. Computational study of human phosphomannose isomerase: Insights from homology modeling and molecular dynamics simulation of enzyme bound substrate.
Xiao J; Guo Z; Guo Y; Chu F; Sun P
J Mol Graph Model; 2006 Nov; 25(3):289-95. PubMed ID: 16488169
[TBL] [Abstract][Full Text] [Related]
13. Identification of Glu173 as the critical amino acid residue for the ADP-ribosyltransferase activity of Clostridium botulinum C3 exoenzyme.
Saito Y; Nemoto Y; Ishizaki T; Watanabe N; Morii N; Narumiya S
FEBS Lett; 1995 Sep; 371(2):105-9. PubMed ID: 7672106
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of the Rho-ADP-ribosylating exoenzyme C3stau2 from Staphylococcus aureus.
Wilde C; Just I; Aktories K
Biochemistry; 2002 Feb; 41(5):1539-44. PubMed ID: 11814347
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions.
de Souza RF; Aravind L
Mol Biosyst; 2012 Jun; 8(6):1661-77. PubMed ID: 22399070
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
Bell CE; Eisenberg D
Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
[TBL] [Abstract][Full Text] [Related]
17. Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation.
Hamza A; Cho H; Tai HH; Zhan CG
Bioorg Med Chem; 2005 Jul; 13(14):4544-51. PubMed ID: 15908215
[TBL] [Abstract][Full Text] [Related]
18. Rho-modifying C3-like ADP-ribosyltransferases.
Aktories K; Wilde C; Vogelsgesang M
Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
[TBL] [Abstract][Full Text] [Related]
19. NAD+ binding site of Clostridium botulinum C3 ADP-ribosyltransferase. Identification of peptide in the adenine ring binding domain using 2-azido NAD.
Chavan AJ; Nemoto Y; Narumiya S; Kozaki S; Haley BE
J Biol Chem; 1992 Jul; 267(21):14866-70. PubMed ID: 1634527
[TBL] [Abstract][Full Text] [Related]
20. Studies on the active-site structure of C3-like exoenzymes: involvement of glutamic acid in catalysis of ADP-ribosylation.
Aktories K; Jung M; Böhmer J; Fritz G; Vandekerckhove J; Just I
Biochimie; 1995; 77(5):326-32. PubMed ID: 8527485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
